Re. Brown et al., COST-ANALYSIS OF ONCE-DAILY ISMN VERSUS TWICE-DAILY ISMN OR TRANSDERMAL PATCH FOR NITRATE PROPHYLAXIS, Journal of clinical pharmacy and therapeutics, 22(1), 1997, pp. 67-76
Objective: To compare the costs and outcomes of treating exercise-indu
ced angina with once-or twice-daily isosorbide mononitrate (ISMN) or t
ransdermal patch. Method: A decision-analytic model was designed based
on published literature showing compliance and increasing symptoms an
d estimates from physicians on treatment patterns and worsening sympto
ms. Results: Data show that patients are more compliant with once-dail
y ISMN (Imdur(R), Astra Hassle, Molndal, Sweden) and patch regimens th
an with twice-daily dose. Based upon the assumption that more complian
t patients are better controlled, the model found that fewer medical c
are resources were consumed by patients treated with the once-daily an
d the patch regimens. The unit cost of the twice-daily ISMN regimen is
40% of the unit cost of the once-daily. Annual costs of treating an e
xercise-induced angina patient are pound 248 for Imdur(R) compared to
pound 250 for the twice-daily ISMN and pound 299 for the transdermal p
atch. Conclusion: Unit prices alone are not good indicators for estima
ting medical management costs.